Analysts Split on Health In Tech as Insurance-Cannabis Bet Plays Out
Wall Street's read on Health In Tech, Inc. (NASDAQ: HIT) is anything but settled. Maxim Group's A. Klee reiterated a "Buy" rating and a $3.00 price target on Friday, August 14th, forecasting a loss